Protein and Antibody Production Solution

protein production serviceBiologicsCorp (BIC) is a biotech CRO specialized in the production of recombinant proteins and antibodies for research and development. Our VISION is to save time and resources for our dear clients by producing custom proteins and antibodies in the most cost-effective manner. With a group of highly experienced and dedicated scientists working in various state-of-the-art production platforms, BIC has successfully produced hundreds/thousands of bacteria, archaea, and eukaryote derived recombinant proteins using bacterial, mammalian cell, and yeast expression systems. BIC can deliver proteins in forms and scales ranging from crude to highly purified, and milligram to sub-kilogram. Proteins can also be delivered per the client's special demands.

BIC provides the best GUARANTEE in the industry – no protein delivery, no billing.

Our one stop gene-to-protein/antibody service simplifies both the starting and end points. The process includes gene optimization and synthesis, protein expression and purification, protein refolding, protein identification, endotoxin control and removal, and fermentation. Other services available include custom peptide synthesis, polyclonal antibody production, monoclonal antibody production, phospho-specific antibody production, and recombinant antibody production.

BIC is determined to provide the best custom services in the industry. Our SIGNATURE is technical support. Each client is assigned a dedicated PhD project manager who provides the highest standard of support to the client. Each PhD project manager oversees all the communication related to a given project starting from the initial inquiry to post-delivery and provides technical, administrative, and logistic support.

BIC, therefore, hopes to become your preferred partner and loyal service provider for all your recombinant protein and antibody needs.


The most recent publication using BiologicsCorp products: McClellan et al (2015) Thrombomodulin Protects Against Bacterial Keratitis, Is Anti-Inflammatory, but Not Angiogenic. Investigative Ophthalmology & Visual Science, 56: 8091-8100.